Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence

We performed longitudinal blood sampling of end-stage kidney disease (ESKD) patients with COVID-19, collecting samples pre-infection and serially during infection. SomaLogic proteomics data were generated for two cohorts. The Wave 1 cohort consists of samples collected from ESKD patients during the first wave of COVID-19 in early 2020, while samples were collected for the Wave 2 cohort in the following year. A full analysis of the dataset is presented in the Nature Communications manuscript (https://doi.org/10.1038/s41467-022-35454-4).